An antiviral drug combination used to treat hepatitis C and an anti-protozoal drug may also work against SARS-CoV-2, researchers say.
![](https://copehealth.org/wp-content/uploads/2022/02/Corona-Virus-1024x683.jpg)
An antiviral drug combination used to treat hepatitis C and an anti-protozoal drug may also work against SARS-CoV-2, researchers say.